JANE STREET GROUP, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$81,890
+74.2%
147,550
+254.7%
0.00%
Q1 2022$47,000
-83.3%
41,600
-66.9%
0.00%
Q4 2021$282,000
-83.1%
125,602
-74.2%
0.00%
Q3 2021$1,664,000
+684.9%
486,397
+588.4%
0.00%
Q2 2021$212,000
+72.4%
70,654
+85.0%
0.00%
Q1 2021$123,000
+485.7%
38,198
+110.0%
0.00%
Q4 2018$21,000
-58.8%
18,187
-52.5%
0.00%
Q2 2016$51,000
-74.4%
38,300
+50.9%
0.00%
-100.0%
Q4 2015$199,000
-10.8%
25,373
+35.4%
0.00%0.0%
Q1 2014$223,00018,7360.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders